Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Investigation of the Immuno-Regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
This study is currently recruiting participants.
Verified by Kaohsiung Medical University Chung-Ho Memorial Hospital, August 2008
Sponsors and Collaborators: Kaohsiung Medical University Chung-Ho Memorial Hospital
Centers for Disease Control and Prevention
Information provided by: Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier: NCT00688389
  Purpose

Research has showed that CLEC5A interacts with dengue virion directly, and is responsible for dengue virus (DV)-induced DAP12 phosphorylation. Data suggests that CLEC5A is a potential therapeutic target for dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). This project will study the genes of CLEC5A, Mannose receptor, DC-SIGN, NALP, decoy receptor 3 (DcR3), Toll-like receptors(TLRs), and (Nod)-like receptors (NLRs) for both DF and DHF groups. In addition, serum level of decoy receptor 3 (DcR3) will be tested. The study will collect the blood samples from 150 healthy persons, 150 persons infected with dengue fever, and 150 persons infected with DHF or DSS.


Condition Intervention
Dengue Fever
Genetic: CLEC5A

MedlinePlus related topics: Dengue Fever Hepatitis
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort
Official Title: Follow-up the Health Condition , Investigation of the Immuno-Regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection

Further study details as provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Estimated Enrollment: 450
Study Start Date: July 2007
Estimated Study Completion Date: June 2009
Groups/Cohorts Assigned Interventions
healthy Genetic: CLEC5A
DF Genetic: CLEC5A
DHF Genetic: CLEC5A

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The samples are obtained from the Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung, Taiwan.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of Dengue fever

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00688389

Contacts
Contact: Jih-Jin Tsai, MD 886-7-312-1101 ext 5677 jijits@cc.kmu.edu.tw

Locations
Taiwan
Kaoshing Medical University Chung-Ho Memorial Hospital Recruiting
Kaoshiung, Taiwan
Contact: Jih-Jin Tsai, MD     886-7-312-1101 ext 5677     jijits@cc.kmu.edu.tw    
Sponsors and Collaborators
Kaohsiung Medical University Chung-Ho Memorial Hospital
  More Information

Responsible Party: Kaohsiung Medical University Chung-Ho Memorial Hospital ( Tsai, Jih-Jin / Dr. )
Study ID Numbers: KMUH-IRB-960195_1, CB9615
Study First Received: May 28, 2008
Last Updated: September 3, 2008
ClinicalTrials.gov Identifier: NCT00688389  
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,
decoy receptor 3 (DcR3), Toll-like receptors(TLRs),
(Nod)-like receptors (NLRs)

Study placed in the following topic categories:
Liver Diseases
Dengue fever
Dengue Hemorrhagic Fever
Hepatitis
Fever
Virus Diseases
Signs and Symptoms
Hemorrhagic Fevers, Viral
Digestive System Diseases
Dengue
Hemorrhagic fever
Viral hemorrhagic fever
Arbovirus Infections

Additional relevant MeSH terms:
RNA Virus Infections
Flaviviridae Infections
Flavivirus Infections
Body Temperature Changes

ClinicalTrials.gov processed this record on January 16, 2009